Home
Inside Ensoma
Our Science
Pipeline
Patients
Careers
News
Contact
Ensoma
Inside Ensoma
About Us
Leadership
Board of Directors
Scientific Advisors
Investors
Our Science
Pipeline
Patients
Our Commitment
Our Treatment Journey
Our Clinical Trials
Expanded Access
Helpful Resources
Careers
News
Press Releases
Presentations
Publications
In the News
Contact
Cytokine Profile in patients with Chronic Granulomatous Disease (CGD)
Post navigation
Previous:
Curative medicines through precision
in vivo
cellular engineering
Next:
In vivo
engineered and lineage-restricted multiplexed CAR-M, -NK, and -T cell therapy mounts robust solid tumor control in pre-clinical models